and clonidine (Jungling, 1968; Onesti et al., 1969) .
Chlorthalidone was associated with both drugs since a diuretic enhances the hypotensive effect of methyldopa (Wilson et al., 1963; Colwil et al., 1964; Smith et al., 1966) and clonidine (Jungling, 1968; Onesti et al., 1969) .
Patients and Methods Selection of Patients
Before admission to the study patients had to fulfil all of the following positive and none of the negative criteria.
Positive Criteria.-A persistently raised diastolic blood pressure (measured in the hospital, in the outpatient clinic, or by the house physician) of 110 mm. Hg or more. A persistent diastolic blood pressure of 90 mm. Hg or more during diuretic treatment (50 mg. of chlorthalidone daily). The patient had to be willing to collaborate and able to record his own blood pressure at home four times each day: recumbent before rising in the morning, standing within five minutes after rising in the morning, standing in the evening before going to bed, and recumbent in the evening after five minutes' rest in bed.
Negative Criteria. The shortest time the patients were on one drug was two months; most of them took each drug during three months, and the longest phase on one drug was four months. The tablets were taken three times a day-on rising in the morning after blood-pressure measurement, at noon, and before sleeping at night after blood-pressure measurement. If fewer than three tablets were taken the noon and morning doses were omitted; if three or more tablets were taken they were divided into three doses, the evening dose being equal to or greater than the others.
Controls
The patients measured their blood pressure at home four times a day and noted the results on a special data sheet, which was handed to the doctor at each outpatient visit. The mean and standard deviations of the last 10 days were calculated and used in the figures given in the Tables.
During each visit to the hypertension clinic three points were checked. (1) The patients were questioned on the nature and number of tablets, and by use of a questionnaire the frequency and importance of side effects were recorded (see Table VIII ). (2) the diastolic pressure. The difference morning and standing evening systolic a during methyldopa and clonidine treat mal. This occurred in three patients during the clonidine phase and in five during methyldopa administration. Sedation in one patient and vomiting in another were severe enough to necessitate interruption of clonidine therapy. During administration of methyldopa side effects were never severe enough to make interruption of treatment necessary.
Discussion Present Data methyldopa adminis-
The study was neither a single nor a double-blind study; pressure are given in the tablets used were similar in taste, colour, and shape to )r the diastolic blood the commercially available tablets of Presinol and Catapres to be smaller during respectively. In most instances these tablets were unknown to [dopa treatment the the patients before the start of the study; they were told that the drugs were different. Furthermore, no special procedures were used to ensure that the patients were in fact taking the tablets given to them on each visit to the hypertension clinic.
Our results showed that in a significantly greater number yldopa phase each of of patients the diastolic morning blood pressure could be set questions (Table  reduced to 95 mm. Hg or less with clonidine-chlorthalidone tion, and drowsiness than with methyldopa-chlorthalidone. Since this difference )01) during clonidine was also seen in the patients not treated previously with one *e frequent headaches of these drugs, the possibility that some of the patients had ine does not consider developed resistance to one of the drugs before the study was ly those in whom the excluded. On average each treatment phase (clonidine or led with both drugs methyldopa) was for about three months, as the number of was the same with pills was usually increased rather slowly and the patients were maintained on the individually maximum dose for one he drug dosage could month. From the present data we do not know if the lood pressure to norobserved difference would also hold during longer periods of treatment. Side effects, however, were more commonly Comparison with Published Data Jungling (1968) Seedat et al. (1969) described 30 patients treated in this way, stating that "effective" control of blood pressure was achieved with both drugs. Nevertheless, clonidine caused side effects in 23 and methyldopa in only 11 of the 30 patients. The nature of the side effects was similar to those described in our study. Smet et (mm. Hg)
.. P Value for these differences al. (1969) mentioned that a dose of 0.4 to 1.2 g. of clonidine is equivalent to 1.5 to 2.0 g. of methyldopa. These data and our present findings agree on the following points: that 0-7 mg. of clonidine corresponds to about 1 g. of methyldopa, that blood-pressure control can be achieved at least as well with clonidine as with methyldopa, and that side effects are more frequent during clonidine than during methyldopa treatment. The present study compares only clonidine-chlorthalidone to methyldopa-chlorthalidone. To specify the exact place of clonidine of prolonged treatment of hypertension a comparative study of clonidine and other antihypertensive agents is desirable.
